# Azurity Pharmaceuticals, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/azurity-pharmaceuticals-inc/bc97bdba-f1c1-4152-99eb-962174d79b31

> Inspection records and compliance data for Azurity Pharmaceuticals, Inc. in Wilmington, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Azurity Pharmaceuticals, Inc.
- FEI Number: 3021346595
- City: Wilmington
- State: Massachusetts
- Country Name: United States
- Address Line 1: 600 Research Dr
- Zip Code: 01887

## Related Documents

- [CRL - Azurity Pharmaceuticals, Inc. - Unknown Date](https://www.keypedia.com/records/crl/azurity-pharmaceuticals-inc/1ec90d9d-8293-476e-ae36-9d4a00614d1b) — source: FDA, date: Invalid Date
- [CRL - Azurity Pharmaceuticals, Inc. - Unknown Date](https://www.keypedia.com/records/crl/azurity-pharmaceuticals-inc/d2ef8944-f9dd-46b1-98c5-6e0480032749) — source: FDA, date: Invalid Date
- [CRL - Azurity Pharmaceuticals, Inc. - Unknown Date](https://www.keypedia.com/records/crl/azurity-pharmaceuticals-inc/0a145a08-53c7-4afe-bfc4-5e3539fc2571) — source: FDA, date: Invalid Date
- [FDA Inspection 1255484 - Azurity Pharmaceuticals, Inc. - 2024-11-14](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/0a94deb7-070c-4c8a-a83d-064cf9d967d6) — classification: No Action Indicated (NAI), source: FDA, date: November 14, 2024
- [WARNING_LETTER - Azurity Pharmaceuticals, Inc. - 2023-03-02](https://www.keypedia.com/records/warning_letter/azurity-pharmaceuticals-inc/8bbd1871-bfb2-4652-9195-d7b242d82ad8) — source: FDA, date: March 2, 2023
- [FDA Inspection 1200074 - Azurity Pharmaceuticals, Inc. - 2023-03-02](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/64bfb086-1201-4189-ba58-78d85ea96314) — classification: No Action Indicated (NAI), source: FDA, date: March 2, 2023
- [EIR - Azurity Pharmaceuticals, Inc. - 2022-02-24](https://www.keypedia.com/records/eir/azurity-pharmaceuticals-inc/82623003-68cd-48b6-b4e3-3ade01aea8a4) — source: FDA, date: February 24, 2022
- [EIR - Azurity Pharmaceuticals, Inc. - 2022-02-24](https://www.keypedia.com/records/eir/azurity-pharmaceuticals-inc/5a265872-1f81-4956-954b-5981dd871143) — source: FDA, date: February 24, 2022
- [EIR - Azurity Pharmaceuticals, Inc. - 2019-07-26](https://www.keypedia.com/records/eir/azurity-pharmaceuticals-inc/7bc82eb3-e97d-48d4-a8cc-f926bfeede8e) — source: FDA, date: July 26, 2019

## Related Companies

- [Pentec Health](https://www.keypedia.com/companies/pentec-health/685ee832-8b77-4209-b00a-35aa6879f13a)
- [Kovas Co., Ltd.](https://www.keypedia.com/companies/kovas-co-ltd/3fa71e84-4ee0-4ce4-97e5-4d2b4e5e71d2)
- [JD & SN Inc.](https://www.keypedia.com/companies/jd-sn-inc/d40c9f93-cd6e-448c-a521-4099d5060814)
- [Pacifico National, Inc. dba AmEx Pharmacy](https://www.keypedia.com/companies/pacifico-national-inc-dba-amex-pharmacy/3e52e884-2941-48eb-b4d1-50f825e2f8ef)
- [Stokes Healthcare Inc. dba Epicur Pharma](https://www.keypedia.com/companies/stokes-healthcare-inc-dba-epicur-pharma/5690f008-b17d-45e0-8976-d917b007f02f)
- [bluebird bio, Inc.](https://www.keypedia.com/companies/bluebird-bio-inc/8225820d-8c44-442b-8df6-583fe3dc7361)
- [ACRX Specialty Pharmacy Inc](https://www.keypedia.com/companies/acrx-specialty-pharmacy-inc/0ec37ad8-7904-4d10-a13c-652d3c6a458f)
- [Kilitch Healthcare India Limited](https://www.keypedia.com/companies/kilitch-healthcare-india-limited/5e04a0e0-736d-4607-a690-db94494f0a32)
- [East Tennessee Clinical Research, Inc](https://www.keypedia.com/companies/east-tennessee-clinical-research-inc/d7ac5584-af1a-448a-8edf-dd487a22fe4a)
- [Trone Health Services, Inc.](https://www.keypedia.com/companies/trone-health-services-inc/33206781-a23d-4cd8-ac88-216148ec389b)

## Related Officers

- [Tonia F. Bernard](https://www.keypedia.com/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)
- [Michael C. Beckloff](https://www.keypedia.com/people/michael-c-beckloff/c45a3b68-4035-4f33-bed5-5c3f05ca4bef)
- [Bharathi Devarakonda, Ph.D., RAC](https://www.keypedia.com/people/bharathi-devarakonda-phd-rac/9ecc0ced-c950-4257-be07-4b4e1ef3ee18)